Blog
RSS FeedPosted by Michael Wonder on 22 Sep 2024
The impact of generic entry of pharmaceuticals in Australia
20 September 2024 - In this article, we estimate the initial and temporal impacts of generic entry on benchmark drug prices ...
Posted by Michael Wonder on 17 Jul 2022
Prescription medication prices to rise
15 July 2022 - The price of nearly 900 prescription medications will rise by as much as $7 on October ...
Posted by Michael Wonder on 21 Mar 2022
New Australian agency to accelerate genomic research and drive innovation in health care
21 March 2022 - Genomics advances will help develop revolutionary treatments for some of our biggest health challenges, including diagnosing ...
Posted by Michael Wonder on 19 Oct 2021
Strategies for generic/biosimilar market entry in Australia
19 October 2021 - After surviving the Great Patent Cliff of 2011–2016, the pharma/biopharma industry finds itself in the Second Great ...
Posted by Michael Wonder on 31 May 2021
Apotex medicines in New Zealand
31 May 2021 - Apotex has announced that it is leaving the New Zealand market. ...
Posted by Michael Wonder on 21 May 2021
PHARMAC to work with others to improve communication
21 May 2021 - PHARMAC accepts the Coroner’s comments that not all information about the brand change reached patients. ...
Posted by Michael Wonder on 17 Mar 2021
PHARMAC’s drug switch
17 March 2021 - PHARMAC's generic drug swap for epilepsy treatment saved $30 million over five years. But for some ...
Posted by Michael Wonder on 04 Mar 2021
PHARMAC swapping epilepsy drugs 'cannot be discounted' as a cause of deaths — neurologist
4 March 2021 - An Auckland paediatric neurologist says PHARMAC's decision to switch to a generic version of an epilepsy drug ...
Posted by Michael Wonder on 24 Feb 2021
PHARMAC knew of epilepsy drug change risks - inquest
24 February 2021 - PHARMAC knew there were clinical reasons some epilepsy patients would not tolerate a change to their ...
Posted by Michael Wonder on 24 Feb 2021
PHARMAC knew of epilepsy drug change risks within some patients, but went ahead with switch
24 February 2021 - PHARMAC knew there were clinical reasons some epilepsy patients would not tolerate a change to their medicines. ...
Posted by Michael Wonder on 23 Feb 2021
Epilepsy drug deaths: Medsafe told PHARMAC it was 'not desirable' to switch brands
23 February 2021 - The medicines safety authority advised PHARMAC it was “not desirable” for patients to switch brands of ...
Posted by Michael Wonder on 22 Feb 2021
Maker of epilepsy drug warned over quality control
23 February 2021 - The drug at the centre of an inquest into six epilepsy deaths was made at a plant ...
Posted by Michael Wonder on 21 Feb 2021
Epilepsy drug deaths: Coronial inquiry into medication-linked deaths resumes
22 February 2021 - A coronial inquiry into the deaths of six patients whose epilepsy medication was changed before they ...
Posted by Michael Wonder on 14 Feb 2021
Does NICE influence the adoption and uptake of generics in the UK?
14 February 2021 - The aim of this paper is to examine generic competition in the UK, with a special focus ...
Posted by Michael Wonder on 30 Nov 2020
GPs tell inquest they were unaware PHARMAC changed their patients' epilepsy drugs
30 November 2020 - Two GPs caring for patients who died after switching brands of an epilepsy drug say they were ...